MedTrace Logo

Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function

NCT06819202 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1309

Last updated 2025-05-14

No results posted yet for this study

Summary

The objective of this observational study was to understand the effect of HBO on patients with SSNHL and its association with coagulation function and prognosis.

The main question it aims to answer is whether HBO therapy can improve outcomes and coagulation function in patients with SSNHL.

The prognosis of SSNHL patients receiving HBO and SSNHL patients not receiving HBO were compared

Conditions

  • Sudden Sensorineural Hearing Loss (SSNHL)
  • Hyperbaric Oxygen Therapy

Interventions

OTHER

Hyperbaric oxygen treatment

HBO therapy is the process of inhaling 100% pure oxygen in an environment above one atmosphere (pressure range: 2.0-3.0 absolute atmospheres) to treat a disease.

Sponsors & Collaborators

  • Sun Yuting

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-06-01
Completion
2025-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06819202 on ClinicalTrials.gov